CN103966352A - Pca3、cst1和cst4在制备前列腺癌标志物中的应用及其试剂盒 - Google Patents
Pca3、cst1和cst4在制备前列腺癌标志物中的应用及其试剂盒 Download PDFInfo
- Publication number
- CN103966352A CN103966352A CN201410235190.5A CN201410235190A CN103966352A CN 103966352 A CN103966352 A CN 103966352A CN 201410235190 A CN201410235190 A CN 201410235190A CN 103966352 A CN103966352 A CN 103966352A
- Authority
- CN
- China
- Prior art keywords
- seq
- pca3
- cst1
- cst4
- psa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
标准品编号 | 浓度(copy/μL) |
STD1 | 100000 |
STD2 | 10000 |
STD3 | 1000 |
STD4 | 100 |
患者编号 | 治疗前后浓度变化百分比 | 临床评价 |
1 | 降低87% | 疗效显著 |
2 | 升高7% | 无效 |
3 | 降低44% | 改善 |
4 | 降低58% | 改善 |
5 | 升高20% | 无效 |
6 | 降低17% | 无效 |
7 | 降低49% | 改善 |
8 | 降低75% | 疗效显著 |
9 | 降低40% | 无效 |
10 | 降低61% | 改善 |
患者编号 | 6周 | 3个月 | 6个月 | 9个月 | 临床评价 |
1 | 0.37 | 0.41 | 0.60 | 0.74 | 转移复发 |
2 | 0.21 | 0.28 | 0.25 | 0.27 | 无进展生存 |
3 | 0.39 | 0.41 | 0.45 | 0.53 | 无进展生存 |
4 | 0.25 | 0.30 | 0.26 | 0.31 | 无进展生存 |
5 | 0.45 | 0.40 | 0.46 | 0.49 | 无进展生存 |
6 | 0.53 | 0.64 | 0.68 | 0.77 | 转移复发 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410235190.5A CN103966352B (zh) | 2014-05-29 | 2014-05-29 | Pca3、cst1和cst4在制备前列腺癌标志物中的应用及其试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410235190.5A CN103966352B (zh) | 2014-05-29 | 2014-05-29 | Pca3、cst1和cst4在制备前列腺癌标志物中的应用及其试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103966352A true CN103966352A (zh) | 2014-08-06 |
CN103966352B CN103966352B (zh) | 2015-07-29 |
Family
ID=51236353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410235190.5A Active CN103966352B (zh) | 2014-05-29 | 2014-05-29 | Pca3、cst1和cst4在制备前列腺癌标志物中的应用及其试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103966352B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105063230A (zh) * | 2015-09-15 | 2015-11-18 | 贾瑞鹏 | 一种检测人类前列腺癌特异性基因的环介导等温扩增试剂盒及其应用 |
CN109762905A (zh) * | 2019-03-11 | 2019-05-17 | 天津脉络医学检验有限公司 | 一种用于辅助检测前列腺癌的ddPCR引物组合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101942523A (zh) * | 2010-10-15 | 2011-01-12 | 邵棠 | 一种检测pca3基因、psa基因的液相芯片法及其诊断试剂盒 |
CN102912030A (zh) * | 2012-11-08 | 2013-02-06 | 端鹏 | 用于前列腺癌早期诊断的引物对、探针和试剂盒 |
CN103740854A (zh) * | 2014-01-29 | 2014-04-23 | 中山大学附属第三医院 | 一种肿瘤标记物及其在制备结直肠癌诊断试剂中的应用 |
-
2014
- 2014-05-29 CN CN201410235190.5A patent/CN103966352B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101942523A (zh) * | 2010-10-15 | 2011-01-12 | 邵棠 | 一种检测pca3基因、psa基因的液相芯片法及其诊断试剂盒 |
CN102912030A (zh) * | 2012-11-08 | 2013-02-06 | 端鹏 | 用于前列腺癌早期诊断的引物对、探针和试剂盒 |
CN103740854A (zh) * | 2014-01-29 | 2014-04-23 | 中山大学附属第三医院 | 一种肿瘤标记物及其在制备结直肠癌诊断试剂中的应用 |
Non-Patent Citations (2)
Title |
---|
前列腺癌基因3的临床研究进展: "庄建等", 《中国医药导报》, vol. 10, no. 10, 30 April 2013 (2013-04-30), pages 32 - 34 * |
张永振等: "前列腺癌相关的部分肿瘤标志物研究进展", 《泌尿外科杂志(电子版)》, vol. 5, no. 3, 31 March 2013 (2013-03-31), pages 39 - 41 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105063230A (zh) * | 2015-09-15 | 2015-11-18 | 贾瑞鹏 | 一种检测人类前列腺癌特异性基因的环介导等温扩增试剂盒及其应用 |
CN105063230B (zh) * | 2015-09-15 | 2019-04-05 | 贾瑞鹏 | 一种检测人类前列腺癌特异性基因的环介导等温扩增试剂盒及其应用 |
CN109762905A (zh) * | 2019-03-11 | 2019-05-17 | 天津脉络医学检验有限公司 | 一种用于辅助检测前列腺癌的ddPCR引物组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103966352B (zh) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Smoczynski et al. | Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary strictures | |
Day et al. | PCA3: from basic molecular science to the clinical lab | |
CN107365852A (zh) | 血清外泌体中肺癌相关microRNA分子标记的应用及其检测试剂盒 | |
CN105603101B (zh) | 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 | |
CN106701964B (zh) | 血清外泌体miRNA生物标志物及用于胃癌早期诊断的试剂盒 | |
CN104004840B (zh) | 用于早期筛查与诊断前列腺癌的试剂盒 | |
CN104946762A (zh) | 检测肺炎克雷伯氏菌的试剂盒 | |
CN108624688B (zh) | hsa_circ_0012755作为前列腺癌分子靶标在制备药物和试剂盒中的应用 | |
CN105671181A (zh) | 用于检测肺癌的基因标志物、引物、探针及试剂盒 | |
CN103937888A (zh) | 鉴别胃癌的血浆microRNA标志物的筛选与应用 | |
CN109576370A (zh) | 用于膀胱癌诊断和复发监控的生物标志物及检测试剂盒 | |
CN105316340A (zh) | Mir27a-3p作为前列腺癌分子标志物及其在诊断试剂盒中的应用 | |
CN103966351B (zh) | CST1mRNA和CST4mRNA或其编码的蛋白质在制备肾癌标志物中的应用及其试剂盒 | |
CN105154447B (zh) | Ac016745.3作为前列腺癌分子靶标及其在诊断试剂盒中的应用 | |
Wang et al. | Plasma expression of miRNA-21,− 214,− 34a, and-200a in patients with persistent HPV infection and cervical lesions | |
CN103966352B (zh) | Pca3、cst1和cst4在制备前列腺癌标志物中的应用及其试剂盒 | |
CN102925444B (zh) | 膀胱癌的血清miRNA生物标志物及其表达量检测方法 | |
CN103849683B (zh) | 前列腺癌尿液检测试剂盒及其应用 | |
CN105154581A (zh) | 一种非小细胞肺癌的诊断和预示方法和生物检测试剂盒 | |
CN105925703A (zh) | 一种筛选肾癌外周血miRNA标志物的方法及肾癌诊断标志物miR-210 | |
CN104611430A (zh) | 一种人类尿液中tmprss2-erg基因检测方法和引物 | |
Hong et al. | Exosomal microRNAs as novel diagnostic biomarkers in breast cancer: A systematic evaluation and meta-analysis | |
CN104046685A (zh) | 用于胃癌的诊断和预后的表观遗传生物标志物adamts9 | |
CN103966350B (zh) | CST1 mRNA和CST4 mRNA或其编码的蛋白质在制备尿道癌标志物中的应用及其试剂盒 | |
CN103966348B (zh) | CST1mRNA和CST4mRNA或其编码的蛋白质在制备膀胱癌标志物中的应用及其试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU MICRO DIAG BIOMEDICINE CO., LTD. Free format text: FORMER OWNER: SHANGHAI DUWEI MEDICAL TECHNOLOGY CO., LTD. Effective date: 20141103 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201507 JINSHAN, SHANGHAI TO: 215123 SUZHOU, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141103 Address after: Suzhou City, Jiangsu Province, Suzhou Industrial Park, 215123 Street No. 218 Nano Technology Park building C4 Room 301 Applicant after: Suzhou Micro Diag Biomedicine Co., Ltd. Address before: 201507 Shanghai city Jinshan District Caojing town industry Road No. 80 Applicant before: SHANGHAI DUWEI MEDICAL TECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151120 Address after: 215000, 99 Industrial Park, Jinji Lake Road, Jiangsu, Suzhou, 16 west of Suzhou Patentee after: PUSHI HUAKANG JIANGSU MEDICAL TECHNOLOGY CO., LTD. Address before: Suzhou City, Jiangsu Province, Suzhou Industrial Park, 215123 Street No. 218 Nano Technology Park building C4 Room 301 Patentee before: Suzhou Micro Diag Biomedicine Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211209 Address after: 200120 all parts of floor 4, building 1, No. 271, Hong Kong Macao Road, pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: SHANGHAI LIANGRUN BIOMEDICAL TECHNOLOGY CO.,LTD. Address before: 215000 building 16, Northwest District, Suzhou nano City, 99 Jinjihu Avenue, Suzhou Industrial Park, Jiangsu Province Patentee before: PUSHI HUAKANG JIANGSU MEDICAL TECHNOLOGY Co.,Ltd. |